Bleichroeder’s Ernexa Therapeutics ERNA Stock Holding History
Bought
Maintained
Sold
Other funds holding ERNA
DIG
Bleichroeder's ERNA Position: Q2 2026 in Review
Bleichroeder sold out of Ernexa Therapeutics (ERNA) in Q2 2026, closing a stake of 80,000 shares — an estimated $398K sold.
Bleichroeder first reported a position in ERNA in Q1 2026 and held it in 1 quarter. The position peaked at $398K in Q1 2026. 9 funds tracked by Wall St. Rank hold ERNA as of Q2 2026.
- Bleichroeder reported no remaining Ernexa Therapeutics position as of Q2 2026 after selling out during the quarter.
- Bleichroeder sold 80,000 Ernexa Therapeutics shares in Q2 2026, an estimated $398K.
- Bleichroeder first reported a position in Ernexa Therapeutics in Q1 2026 and held it in 1 quarter.
- Bleichroeder's Ernexa Therapeutics position peaked at $398K in Q1 2026.
- 9 funds tracked by Wall St. Rank held Ernexa Therapeutics as of Q2 2026.
Based on Bleichroeder's 13F filing for Q2 2026, filed 13 Aug 2026.